ARTL
Artelo Biosciences·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ARTL fundamentals
Artelo Biosciences (ARTL) released its earnings on Aug 13, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -5.61 (YoY -648.00%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-5.61
-648.00%
Report date
Aug 13, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Artelo Biosciences (ARTL) key financial stats and ratios, covering profitability, financial health, and leverage.
Artelo Biosciences (ARTL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Artelo Biosciences (ARTL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Artelo Biosciences (ARTL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Artelo Biosciences (ARTL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Artelo Biosciences (ARTL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Artelo Biosciences's management provide for the next earnings period?What factors drove the changes in Artelo Biosciences's revenue and profit?What does Artelo Biosciences do and what are its main business segments?What were the key takeaways from Artelo Biosciences's earnings call?What is Artelo Biosciences's gross profit margin?What were the key takeaways from Artelo Biosciences’s earnings call?What is the revenue and EPS growth rate for Artelo Biosciences year over year?Did Artelo Biosciences beat or miss consensus estimates last quarter?
